Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Safety and Efficacy Study of PVX108 in Children and Adolescents With Peanut Allergy

NCT05621317 is registered in ClinicalTrials.gov with Aravax Pty Ltd as lead sponsor.

NCT NCT05621317
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05621317 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Safety and Efficacy Study of PVX108 in Children and Adolescents With Peanut Allergy
Lead sponsor
Aravax Pty Ltd
Phase
Phase 2
Overall status
Active, not recruiting
Start date
February 9, 2023
Completion date
June 30, 2027
Enrollment
90 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

immune system diseases, peanut allergy, peanut hypersensitivity, peanut-induced anaphylaxis